News

The plant, in the city of Nanning in Guangxi province, has been set up in collaboration with a European pharmaceutical company for which Evonik is expected to produce

Ever since FDA has approved the TIDE trial in 2007, Avandia has been linked to an increased risk of heart attacks. Now with the regulator mulling to halt

Emerging World Pharma is an investor in generic based pharmaceutical companies manufacturing within developing nations. Emerging World Pharma said that the investment will be used to fund generic

In the open-label Phase I/II study, 67 patients with advanced pancreatic cancer were treated. Patients were 18 years of age and older with histologically confirmed metastatic adenocarcinoma of

Mr Connors will join Prestige Brands from Matrixx Initiatives, a Phoenix-based consumer products marketer of OTC products, where he served as vice president of marketing and prior to

Five new products approved for commercial sale in Japan comprise three new medical entities; Nesina for treatment of type 2 diabetes, Rozerem for treatment of insomnia and anti-cancer

The trial was designed to test the Immuron hyperimmune antibody product BioGard as adjunct therapy to support the immune system of HIV patients undergoing long-term treatment with anti-retroviral

Roche pharmaceuticals division’s sales increased 6% to CHF9.7bn from CHF9.2bn for the prior year period. Diagnostics division’s sales were CHF2.5bn, an increase of 7%, compared to CHF2.3bn for

In a statement regarding the introduction of the ‘Safe Chemicals Act of 2010’ in the US Senate, Frank Lautenberg, US Senator, said: “SOCMA supports efforts to promote the